Product Information
GLYBURIDE 5 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0655 per EA under NDC 00093936405. Its NADAC has been published 619 times since Nov 28, 2013.
FDA first approved this application on May 1, 1984. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093936405
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
GLYBURIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA017532FDA Approved
5/1/1984
TE Code
AB2
On Market Since
5/1/1984
Pharmacological Classes
Price Statistics
The NADAC for GLYBURIDE 5 MG TABLET has been published 619 times since Nov 28, 2013, and over the history we have for it it has declined 58.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0655 per EA |
|---|---|
| All-time high | $0.1774 (Feb 12, 2014) |
| All-time low | $0.0502 (May 22, 2024) |
| 52-week high | $0.0655 |
| 52-week low | $0.0599 |
| Median price | $0.1015 |
| Average price | $0.1075 |
| Largest weekly change | +40.3% (Feb 22, 2023) |
| Weeks tracked | 619 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+9.4%
3Y
-26.7%
5Y
-41.3%
All
-58.5%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GLYBURIDE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLYBURIDE 5 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0655 per EA (NDC 00093936405), effective Oct 1, 2025.
How has the price of GLYBURIDE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLYBURIDE 5 MG TABLET has declined 58.5%. It has been tracked across 619 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GLYBURIDE 5 MG TABLET?
Since Nov 28, 2013, the NADAC for GLYBURIDE 5 MG TABLET has ranged from a low of $0.0502 (May 22, 2024) to a high of $0.1774 (Feb 12, 2014), with a median of $0.1015 per EA.
Are there cheaper alternatives to GLYBURIDE 5 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLYBURIDE 5 MG TABLET, is $0.0639 per EA — about 3% below GLYBURIDE 5 MG TABLET.
Who manufactures GLYBURIDE 5 MG TABLET?
GLYBURIDE 5 MG TABLET (NDC 00093936405) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.